Celiac Disease and Dermatitis Herpetiformis

By SWA

Celiac disease is a chronic autoimmune disorder primarily affecting the small intestine, triggered by the ingestion of gluten in genetically predisposed individuals. It is characterized by an inappropriate immune response to gluten, a protein found in wheat, barley, and rye. This immune reaction leads to inflammation and damage to the small intestine's lining, impairing nutrient absorption.

Dermatitis Herpetiformis: A Cutaneous Manifestation of Celiac Disease

Dermatitis herpetiformis (DH) is a distinct, pruritic skin condition often associated with celiac disease. It is considered the cutaneous manifestation of gluten-sensitive enteropathy (GSE). This autoimmune disorder predominantly affects adults and is less common in children. DH is characterized by intensely itchy, blistering skin eruptions that are symmetrically distributed on the extensor surfaces of the body, including the elbows, knees, buttocks, and back.

Pathophysiology

The underlying mechanism of DH involves an immune response to dietary gluten, leading to the production of immunoglobulin A (IgA) antibodies. These antibodies target tissue transglutaminase (tTG) and epidermal transglutaminase (eTG) enzymes. The IgA-tTG complexes are deposited in the papillary dermis of the skin, triggering an inflammatory response and resulting in the formation of the characteristic lesions.

Clinical Presentation

Patients with DH typically present with:

  • Pruritic Vesicles and Papules: These small, fluid-filled blisters and red, raised bumps are intensely itchy.
  • Grouped Excoriations and Erosions: Due to the severe itching, lesions are often scratched, leading to erosions.
  • Symmetric Distribution: Lesions are commonly found on the extensor surfaces of the elbows, knees, buttocks, and back.
  • Erythematous Urticarial Plaques: Red, swollen patches of skin resembling hives are also common.

Diagnosis

The diagnosis of DH involves a combination of clinical evaluation, laboratory tests, and skin biopsy:

  • Physical Examination: Identifies the characteristic distribution and appearance of lesions.
  • Blood Tests: Detect antibodies associated with celiac disease, including anti-tTG and anti-eTG antibodies.
  • Skin Biopsy: A biopsy of unaffected skin adjacent to a lesion, followed by direct immunofluorescence, reveals granular IgA deposits in the dermal papillae.

Additionally, screening for celiac disease through serologic tests and duodenal biopsy is recommended, as a significant proportion of DH patients have concurrent celiac disease.

Treatment

The primary treatment for DH and celiac disease is a strict, lifelong gluten-free diet. This dietary modification helps in reducing the production of offending antibodies and alleviates symptoms of both intestinal and skin manifestations. Adherence to a gluten-free diet can lead to a significant reduction in the need for medications and improve the overall quality of life.

For immediate relief of itching and skin lesions, dapsone, a sulfone antibiotic, is often prescribed. However, it is crucial to monitor for potential side effects of dapsone, including hemolysis and methemoglobinemia. Other therapeutic options include sulfapyridine or sulfamethoxypyridazine for patients intolerant to dapsone.

Conclusion

Dermatitis herpetiformis is a significant cutaneous manifestation of celiac disease, necessitating awareness among healthcare providers for timely diagnosis and management. A combination of a gluten-free diet and appropriate medication can effectively manage symptoms, improving patient outcomes. Concurrent screening for celiac disease is essential, given the strong association between these two conditions.

References

  1. Collin, P., & Reunala, T. (2003). Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists. American Journal of Clinical Dermatology, 4(1), 13-20.
  2. Green, P. H. R., & Jabri, B. (2006). Coeliac disease. The Lancet, 367(9515), 181-190.
  3. Zone, J. J. (2005). Skin manifestations of celiac disease. Gastroenterology, 128(4), S87-S91.
  4. AGA Institute. (2006). American Gastroenterological Association medical position statement on the diagnosis and management of celiac disease. Gastroenterology, 131(6), 1977-1980.
  5. Reunala, T., Salmi, T. T., Hervonen, K., Laurila, K., & Kautiainen, H. (2008). Dermatitis herpetiformis: a common extraintestinal manifestation of coeliac disease. Clinical Reviews in Allergy & Immunology, 36(2-3), 56-61.

Note: By reading my blog, you acknowledge that I do not provide medical diagnoses or treatments. The information provided is meant to answer frequently asked questions and is gathered from reputable scientific papers.

 

Comments

Post a Comment

Popular posts from this blog

Is ME CFS Spinal Muscular Atrophy (SMA)?

By SWA
After a 70-year journey filled with multiple incorrect diagnoses and just as many inappropriate treatments, I finally found an answer to my progressive muscle weakness. Throughout this time, I faced insults and was labeled lazy for my inability to walk long distances or up hills, climb steps, or carry heavy loads. I couldn't ride a bike because sitting on the saddle was impossible. My school grades suffered due to insufficient performance in sports. Instead of receiving comfort from my parents, I was pushed into hard work to strengthen my muscles. Doctors also advised me to exercise my muscles. My life continued with reduced activity, as I had to avoid or quit jobs where standing for extended periods was required or where I couldn't support my skeletal muscle weakness by bracing my elbows. The most excruciatingly painful and weakest period, when I could barely walk, occurred at age 20, during pregnancy. In 2008, an MRI referred by my endocrinologist for permanent adrenal
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By SWA
Image
Could a virus be the stimulus for cytokine production?   It is well established, but rarely  tested, that a cytokine storm is an overactive immune response characterized by the excessive release of pro-inflammatory cytokines. ( ANA, CRP, and CBC tests are necessary) It can occur in various conditions, such as severe infections (e.g., COVID-19), (and other viruses), autoimmune diseases, and after certain treatments.  Serositis and lymphopenia are common features of systemic lupus erythematosus following SARS-CoV-2 infection: A case report and literature review These cells are called NKG2D+CD8+ T cells and researchers say their aggressive response is responsible for neurological damage suffered from infections beyond just Zika, like COVID-19 and even septic shock. The aggressive response is the result of the body producing large amounts of inflammatory proteins called cytokines, which in moderation help to coordinate the body’s response in battling an infection or injury by
Read more

Strange fibrous clots

By SWA
 AI evaluated: The image shows a table listing various proteins with their corresponding percentages and ranks. These results appear to be from a protein analysis, possibly from a blood sample or a proteomic study. Each row represents a different protein, with the following columns: Protein Name: The name of the protein detected in the sample. Percentage (%): The relative abundance of each protein, indicating its proportion in the sample. Rank (#): The rank of each protein based on its relative abundance. Here is a brief interpretation of some of the listed proteins and their potential significance: Fibrinogen beta chain (35.2848%) and Fibrinogen gamma chain (16.0694%): High levels of fibrinogen proteins suggest a response to injury or inflammation, as fibrinogen is essential for blood clot formation. Hemoglobin subunit beta (14.0401%) and Hemoglobin subunit alpha (2.8530%): Presence of hemoglobin subunits indicates red blood cells or hemolysis in the sample. Actin, cytoplasmic 1
Read more